Tag: Subscription

Browse our exclusive articles!

Firm Exposes Fleeceware Using ChatGPT | Lorenz S. Marasigan

Beware of ChatGPT-based fleeceware apps using AI to overcharge users. Sophos warns that these apps, disguised as legitimate chatbots, coerce users into costly subscriptions. Follow platform guidelines to unsubscribe and report unethical developers.

Tesla Stock Poised for ‘ChatGPT Moment’ Amidst Potential Growth Opportunities.

Analysts predict a potential ChatGPT moment for Tesla, akin to Nvidia's exponential growth after an AI surge. One way to spur Tesla's momentum is by adjusting the price of its costly full self-driving software, which could incentivize more customers to buy and generate excitement for the company. Canaccord's analyst rates Tesla shares as a Buy with a $257 target price for the stock.

Sophos Unravels ChatGPT Apps Scamming Users

Beware of fraudulent chatbot apps! Cybersecurity firm Sophos discovered ChatGPT-based apps that trick users into expensive subscriptions. #cybersecurity #ChatGPT #fraudulentapps

Beware of Fake ChatGPT Apps – They Can Steal Your Money – Uninstall Immediately If You Already Installed

ChatGPT, OpenAI's popular AI-based chatbot, is easy prey for online scammers. Recently, Sophos noticed fake ChatGPT apps on Google Play Store and Apple App Store. These unethical apps are nothing but "fleeceware" – users get bombarded with ads at the end of their trial and asked to pay a hefty subscription fee. Be aware, opt for the real OpenAI ChatGPT and stay safe!

Increasing Number of Scam ChatGPT Apps in App Stores

Be aware of fleeceware apps pretending to be ChatGPT! Discover how attackers are taking advantage of artificial intelligence popularity and deception. Learnmore about OpenAI company and Sean Gallagher from Sophos. Protect yourself!--

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img